Summit Therapeutics to Present at the 2019 BIO Investor Forum
16 Octobre 2019 - 1:00PM
Summit Therapeutics plc (‘Summit’ or the
‘Company’)
Summit Therapeutics to Present at the 2019 BIO Investor
Forum
Oxford, UK, and Cambridge, MA, US, 16 October
2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM)
announces that Mr Glyn Edwards, Chief Executive Officer, will
present at the 2019 BIO Investor Forum on 22 October 2019 at
10:45am PDT in San Francisco.
A live webcast of the presentation will be
available in the Investors section of the Company's website,
www.summitplc.com. A replay of the webcast will be available from
the same location soon after the live presentation.
About Summit Therapeutics Summit
Therapeutics is a leader in antibiotic innovation. Our new
mechanism antibiotics are designed to become the new standards of
care for the benefit of patients and create value for payors and
healthcare providers. We are currently developing new mechanism
antibiotics for infections caused by C. difficile, N. gonorrhoeae
and Enterobacteriaceae and are using our proprietary Discuva
Platform to expand our pipeline. For more information, visit
www.summitplc.com and follow us on Twitter @summitplc.
Contacts
Summit |
|
|
Glyn Edwards / Richard Pye (UK office) |
Tel: |
44 (0)1235 443 951 |
Michelle Avery (US office) |
|
+1 617 225 4455 |
|
|
|
Cairn Financial Advisers LLP (Nominated Adviser) |
Tel: |
+44 (0)20 7213 0880 |
Liam Murray / Tony Rawlinson |
|
|
|
|
|
N+1 Singer (Joint Broker) |
Tel: |
+44 (0)20 7496 3000 |
Aubrey Powell / Jen Boorer, Corporate FinanceTom Salvesen,
Corporate Broking |
|
|
|
|
|
Bryan Garnier & Co Limited (Joint Broker) |
Tel: |
+44 (0)20 7332 2500 |
Phil Walker / Dominic Wilson |
|
|
MSL Group (US) |
Tel: |
+1 781 684 6652 |
Erin Anthoine |
|
summit@mslgroup.com |
|
|
|
Consilium Strategic Communications (UK) |
Tel: |
+44 (0)20 3709 5700 |
Mary-Jane Elliott / Sue Stuart / Sukaina Virji |
|
summit@consilium-comms.com |
Lindsey Neville |
|
|
-END-
Summit Therapeutics (NASDAQ:SMMT)
Graphique Historique de l'Action
De Juil 2024 à Août 2024
Summit Therapeutics (NASDAQ:SMMT)
Graphique Historique de l'Action
De Août 2023 à Août 2024